Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine

Consensus

Download PDF

Paperback - $39.60
Ebook - $32.39

Request an exam or desk copy

Advances in biomedical science, data science, engineering, and technology are leading to high-pace innovation with potential to transform health and medicine. These innovations simultaneously raise important ethical and social issues, including how to fairly distribute their benefits and risks. The National Academies of Sciences, Engineering, and Medicine, in collaboration with the National Academy of Medicine, established the Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine to provide leadership and engage broad communities in developing a framework for aligning the development and use of transformative technologies with ethical and equitable principles. The committees resulting report describes a governance framework for decisions throughout the innovation life cycle to advance equitable innovation and support an ecosystem that is more responsive to the needs of a broader range of individuals and is better able to recognize and address inequities as they arise.

Additional materials

Publication information

242 pages · 6 x 9 · paperback
ISBN Paperback: 0-309-70761-7
ISBN Ebook: 0-309-70762-5
DOI: https://doi.org/10.17226/27184

Suggested citation

National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2023. Toward Equitable Innovation in Health and Medicine: A Framework. Washington, DC: The National Academies Press.

Import this citation to:

Keith Wailoo

Keith Wailoo, PhD (NAM) is Henry Putnam University Professor of History and Public Affairs. He is jointly appointed in the Department of History and in the Princeton School of Public and International Affairs. Dr. Wailoo is former Vice Dean of the School of Public and International Affairs, former Chair of History, and former President of the American Association for the History of Medicine (2020-2022). His research straddles history and health policy, touching on drugs and drug policy, on the politics of race and health, on the interplay of identity, ethnicity, gender, and medicine, and on controversies in genetics and society. In 2021, Dr. Wailoo received the Dan David Prize for his "influential body of historical scholarship focused on race, science, and health equity; on the social implications of medical innovation; and on the politics of disease." His writings have advanced historical and public understanding on a range of topics: racial disparities in health care, the cultural politics of pain and opioids, how pandemic change societies, and the FDA's decision to ban menthol cigarettes. Before joining the Princeton faculty, Professor Wailoo taught in History and in Social Medicine (in the Medical School at UNC Chapel Hill), and at Rutgers University where he was Martin Luther King Jr. Professor of History and jointly affiliated with the History department and the Institute for Health, Health Care Policy, and Aging Research. He holds a Ph.D. in the History and Sociology of Science from the University of Pennsylvania, and a Bachelor’s Degree in Chemical Engineering from Yale University. He was elected to the National Academy of Medicine and the American Academy of Arts and Sciences and is the recipient of numerous other academic honors. As of May 24. 2023 he was elected a member of the board of directors for the Greenwall Foundation.

Keith R. Yamamoto

Keith R. Yamamoto, PhD (NAS/NAM) is University of California, San Francisco (UCSF) vice chancellor for science policy and strategy, director of precision medicine for UCSF, and professor of cellular and molecular pharmacology at UCSF. He is a leading researcher investigating transcriptional regulation by nuclear receptors, which mediate the actions of essential hormones and cellular signals; he uses mechanistic and systems approaches to pursue these problems in pure molecules, cells and whole organisms. He has led or served on numerous national committees focused on public and scientific policy, public understanding and support of biological research, science education, and diversity, equity and inclusion and anti-racism; he chairs the Coalition for the Life Sciences, co-chairs the NASEM Roundtable on Aligning Incentives for Open Science, and is vice chair of the Advisory Council for the California Initiative to Advance Precision Medicine; he sits on the Board of Directors of the Public Library of Science, the Board of Directors of Rapid Science, the Governing Board of the California Institute for Regenerative Medicine, the Oversight Committee of the California Institute for Regenerative Medicine, the Board of Counselors for the Radiation Effects Research Foundation, and the Advisory Board for Lawrence Berkeley National Laboratory. He has chaired or served on many committees that oversee training and the biomedical workforce, research funding, and the process of peer review and the policies that govern it at the National Institutes of Health. He was elected to the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Academy of Microbiology, and is a fellow of the American Association for the Advancement of Science.

Amy P. Abernethy

Amy Abernethy, MD, PhD is the President of Product Development and Chief Medical Officer at Verily, where she leads teams in the development and delivery of products that bridge the gap between clinical research and care. Before joining Verily, Dr. Abernethy was Principal Deputy Commissioner and Acting Chief Information Officer of the US Food and Drug Administration. Prior roles include serving as Chief Medical Officer, Chief Scientific Officer, and Senior Vice President of Oncology of Flatiron Health and multiple roles at Duke University, where she was Professor of
Medicine. Dr. Abernethy is a hematologist/oncologist and palliative medicine physician who has authored more than 500 publications. Dr. Abernethy went to the University of Pennsylvania and then Duke University Medical School, and received her PhD from Flinders University in Australia.

David A. Asch

David A. Asch, MD, MBA (NAM) is senior vice dean for strategic initiatives at the Perelman School of Medicine and John Morgan professor at the Perelman School and the Wharton School at the University of Pennsylvania He created and from 2001 to 2012 directed the Center for Health Equity Research and Promotion -- the Department of Veterans Affairs’ health services research center to understand and eliminate racial disparities in health and health care. From 1998 to 2012 he was Executive Director of the Leonard Davis Institute of Health Economics. His research is in the area of behavioral economics and aims to understand and improve how physicians and patients make medical choices. He is an elected member of the National Academy of Medicine and he has received awards for teaching, mentorship, scholarship, and innovation.

Olveen Carrasquillo

Olveen Carrasquillo, MD, MPH is a Professor of Medicine and Public Health Sciences and Associate Dean for Clinical and Translational Research at the University of Miami’s Miller School of Medicine. He is a Puerto Rican born physician who was raised in the Bronx and obtained his MD degree from the New York University School of Medicine. He completed a three-year internal medicine residency at Columbia-Presbyterian Medical Center, Harvard’s two-year General Medicine Fellowship and an MPH from the Harvard School of Public Health. For eight years, he was Director of the Center of Excellence in Health Disparities Research at Columbia University. For thirteen years he served as Chief of the Division of General Internal Medicine at the University of Miami where he led a clinical, teaching and research enterprise of 51 full time faculty. Dr. Carrasquillo now serves as co-Director of the University’s Clinical and Translational Science Institute, whose mission is to drive research translation into evidence-based clinical and community practices to improve the health of South Florida’s diverse population. Since the COVID pandemic began, he has helped lead the health systems institutional response to COVID and took a lead role in community education, including numerous media appearances and presentations to community groups. He is also leading the NIH-sponsored Florida Community-Engaged Research Alliance Against COVID-19 in Disproportionately Affected Communities (FL-CEAL). Dr. Carrasquillo is a national expert in minority health, health disparities, community based participatory research, access to care and community health worker interventions. He is also active in national organizations including current and past leadership roles in the Society of General Internal Medicine, Physicians for a National Health Program, National Hispanic Medical Association and Latinos for Health Equity. In Miami, he is a Board Member of the Miami-Dade Area Health Education Center and the South Florida Health Council. He is often called upon by the media to discuss his research as well as health care topics of particular relevance to the Hispanic community.

Amitabh Chandra

Amitabh Chandra, PhD, MS (NAM) is the Ethel Zimmerman Wiener Professor of Public Policy and Director of Health Policy Research at the Harvard Kennedy School of Government, and the Henry and Allison McCance Professor of Business Administration at Harvard Business School where he directs the joint MS/MBA program in the life-sciences. His wife works at Ginkgo Bioworks. Dr. Chandra is a member of the Congressional Budget Office's (CBO) Panel of Health Advisors, and is a Research Associate at the National Bureau of Economic Research (NBER). His research focuses on innovation and pricing in the biopharmaceutical industry, value in health care, medical malpractice, and racial disparities in healthcare. His research has been supported by the National Institute of Aging, the National Institute of Child Health and Development, the Robert Wood Johnson Foundation, and has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the Chair Editor of the Review of Economics and Statistics. Dr. Chandra is an elected member of the National Academy of Medicine and the National Academy of Social Insurance.

R. A. Charo

R. Alta Charo, JD (NAM) is professor emerita of law and bioethics at the University of Wisconsin, and now works as an independent consultant to government and industry on medical and biotechnology ethics, policy and governance related to human therapeutics, agriculture, species conservation and national security. She was a member of President Clinton’s National Bioethics Advisory Commission and worked as a legal and policy analyst for the former congressional Office of Technology Assessment, the US Agency for International Development and the FDA. Charo has been elected to the AAAS and the American Academy of Arts and Sciences, as well as the NAM. Charo is a member of the AAAS committee on science, engineering, and public policy, and has consulting contracts with BioMADE, DARPA, Colossal, eGenesis, Vertex, Johnson & Johnson, Gameto, and Warner Bros. Entertainment. She also serves as a member of the National Academies committee on science, technology, and law (CSTL), and has co-chaired committees on guidelines for embryonic stem cell research, the committee on genome editing governance, and the committee on emerging science and technology innovation (CESTI).

Hana El-Samad

Hana El-Samad, PhD is a founding Principal Investigator at Altos Labs and a Professor in the Department of Biochemistry & Biophysics and deputy-director of the Cell Design Institute at UCSF. She is a control and dynamical systems theorist whose work generated fundamental insights into the principles of precise and robust cellular responses through the use of feedback control. Her recent work pioneered real-time measurement of feedback in living cells, synthetic feedback technologies to program cellular function, and theoretical frameworks to quantify biological homeostasis. Dr. El-Samad is the founding editor in chief of GEN Biotechnology, and a staunch advocate for the diversification of the STEM workforce. Dr. El-Samad is the recipient of many honors and awards including a 2011 Donald P. Eckman Award. 2013 Paul G. Allen Distinguished Investigator, 2017 senior investigator of the Chan-Zuckerberg Biohub and 2020 Fellow of the American Institute for Medical and Biological Engineering.

Michele B. Goodwin

Michele Bratcher Goodwin, JD, LLM, SJD, is Linda D. & Timothy J. O'Neill Professor of Constitutional Law and Global Health Policy and Georgetown Law School. She was previously Chancellor’s Professor at the University of California, Irvine and Senior Lecturer at Harvard Medical School. Previously, she served as the Everett Fraser Professor at the University of Minnesota, with faculty appointments in the law school, medical school, and school of public health. She directed the first ABA accredited health law program in the nation and founded the first law center focused on race and bioethics. Her primary areas of research span constitutional law, bioethics, and health law policy. Professor Goodwin is the author of six books and over one hundred articles, book reviews, and commentaries. She is the recipient of the 2020-21 Distinguished Faculty Award, the highest honor bestowed in the University of California system. In 2022, she received the distinguished Margaret Brent Award from the American Bar Association. She was a Gilder Lehrman Post Doctoral Fellow at Yale University, and earned her SJD and LLM (as well as BA) from the University of Wisconsin. She earned her JD from Boston College.

Anthony Hatch

Anthony Ryan Hatch, Ph.D., is a sociologist and Associate Professor of Science in Society at Wesleyan University where is he is affiliated faculty in the Department of African American Studies, the College of the Environment, and the Department of Sociology. He is the author of Silent Cells: The Secret Drugging of Captive America (Minnesota, 2019) and Blood Sugar: Racial Pharmacology and Food Justice in Black America (Minnesota, 2016). He teaches and lectures widely on health systems, medical technology, and social inequalities. He is a member of the Sydney Center for Healthy Societies, the Health and Social Equities Collaborative at King’s College London, and is a fellow in The Hastings Center. Dr. Hatch also serves on the Wellcome Trust Medical Humanities Discovery Advisory Group and the Community Development Community Advisory Council of the Federal Reserve Bank of Boston. He is on the editorial boards of Science, Technology & Human Values and the Social History of Alcohol and Drugs. At Wesleyan, Dr. Hatch is the director of Black Box Labs, an undergraduate research and training laboratory that offers students training in qualitative research methods in science and technology studies and the opportunity to collaborate with faculty on social research.

Jianying Hu

Jianying Hu, PhD is IBM Fellow; Global Science Leader, AI for Healthcare and Director of HCLS Research at IBM Research; and Adjunct Professor at Icahn School of Medicine at Mount Sinai. Prior to joining IBM in 2003 she was with Bell Labs at Murray Hill, New Jersey. Dr. Hu has conducted and led extensive research in machine learning, data mining, statistical pattern recognition, and signal processing, with applications to healthcare analytics and medical informatics, business analytics, and multimedia content analysis, with recent efforts focusing on advanced computational methods for deriving data-driven insights from real world healthcare data. She has published over 140 peer reviewed scientific papers and holds 48 patents. Dr. Hu served as Chair of the Knowledge Discovery and Data Mining (KDDM) Working Group of the American Medical Informatics Association (AMIA) from 2014 to 2016, and on the Computational Science Advisory Board of Michael J. Fox Foundation from 2017 to 2018. She has served as Associate Editor for many journals including IEEE TPAMI, IEEE TIP, and Pattern Recognition, and currently serves on the Journals and Publications Committee of AMIA, Editorial Board of JAMIA Open, the Advisory Board of JHIR, and the External Advisory Board of Vanderbilt University Department of Biomedical Informatics. Dr. Hu is a fellow of the American College of Medical Informatics (ACMI), International Academy of Health Sciences Informatics (IAHSI), IEEE, and the International Association of Pattern Recognition (IAPR). She received the Asian American Engineer of the Year Award in 2013.

Lisa I. Iezzoni

Lisa Iezzoni, MD, MSc (NAM) is professor of medicine at Harvard Medical School, based at the Health Policy Research Center, Mongan Institute, Massachusetts General Hospital and a 2022-2023 fellow of the Harvard Radcliffe Institute. After spending 16 years as co-director of research in the Division of General Medicine and Primary Care at Boston’s Beth Israel Deaconess Medical Center, she joined the then Institute for Health Policy at Massachusetts General Hospital as associate director in 2006 and served as its director from 2009-2018. Her early research focused on risk adjustment methods for predicting cost and clinical outcomes of care; since 1998, she has studied the lived experiences, health, and health care services of persons with disabilities. She served on the National Committee on Vital and Health Statistics and the Secretary’s Advisory Committee on Health Promotion and Disease Prevention Objectives for 2020. She has served on the editorial boards of the Annals of Internal Medicine, the Journal of General Internal Medicine, Health Affairs, Medical Care, Health Services Research, and the Disability and Health Journal, among others. She is a member of the National Academy of Medicine. She has an M.D. from Harvard Medical School and an M.Sc. from the Harvard School of Public Health.

Alex John London

Alex John London, PhD, MA is the Clara L. West Professor of Ethics and Philosophy and Director of the Center for Ethics and Policy at Carnegie Mellon University. An elected Fellow of the Hastings Center, Professor London’s work focuses on ethical and policy issues surrounding the development and deployment of novel technologies in medicine, biotechnology and artificial intelligence, on methodological issues in theoretical and practical ethics, and on cross-national issues of justice and fairness. His book, For the Common Good: Philosophical Foundations of Research Ethics, is available as an open access title from Oxford University Press (2021). He was previously a member of the National Academy of Medicine Committee on Clinical Trials During the 2014-2015 Ebola Outbreak, and was a member of the World Health Organization (WHO) Expert Group on Ethics and Governance of AI whose report “Ethics and governance of artificial intelligence for health” was published in 2001. He previously served on the U.S. Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability and he is currently a member of the U.S. National Science Advisory Board for Biosecurity (NSABB). He also serves on the board of directors for the International Association of Bioethics. He has authored more than 100 papers or book chapters that have appeared in venues such as Mind, The Philosopher’s Imprint, Science, JAMA, The Lancet, The BMJ, PLoS Medicine, Statistics In Medicine, The Hastings Center Report, and numerous other journals and collections. He is also co-editor of Ethical Issues in Modern Medicine, one of the most widely used textbooks in medical ethics.

Debra Mathews

Debra Mathews, PhD, MA is the Assistant Director for Science Programs for the Johns Hopkins Berman Institute of Bioethics and an Associate Professor in the Department of Genetic Medicine, Johns Hopkins School of Medicine. She is also the Ethics and Governance Lead for the Johns Hopkins Institute for Assured Autonomy. Her academic work focuses on ethics and policy issues raised by emerging technologies, with particular focus on genetics, stem cell science, neuroscience, synthetic biology, and artificial intelligence. In addition to her academic work, Dr. Mathews has spent time at the Genetics and Public Policy Center, the US Department of Health and Human Services, the Presidential Commission for the Study of Bioethical Issues, and the National Academy of Medicine working in various capacities on science policy. Dr. Mathews is an ad hoc members of the Working Group on Data Science and Emerging Technology of the NIH NExTRAC and a member of the Board of Directors of the International Neuroethics Society. In 2020, she was elected as a Fellow of the Hastings Center. Dr. Mathews earned her PhD in genetics from Case Western Reserve University, as well as a concurrent Master’s in bioethics. She completed a Post-Doctoral Fellowship in genetics at Johns Hopkins, and the Greenwall Fellowship in Bioethics and Health Policy at Johns Hopkins and Georgetown Universities.

Shobita Parthasarathy

Shobita Parthasarathy, PhD is Professor of Public Policy and Women’s and Gender Studies, and Director of the Science, Technology, and Public Policy Program, at University of Michigan. Her research focuses on the social, ethical, equity, historical, and policy dimensions of science and technology, in comparative and international perspective. She has published widely on genetics and biotechnology, intellectual property, innovation policy, and artificial intelligence. She is the author of numerous articles and two books: Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care (MIT Press, 2007) and Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe (University of Chicago Press, 2017). The former influenced the 2013 US Supreme Court case that determined human genes were not patentable; the latter won the 2018 Robert K. Merton Award from the American Sociological Association. She writes frequently for public audiences, and co-hosts The Received Wisdom podcast. She has held fellowships from the American Council for Learned Societies, the Woodrow Wilson International Center for Scholars, and Max Planck Institute for Innovation and Competition. She holds a Bachelor’s degree in Biology from University of Chicago, and Masters and PhD degrees in Science and Technology Studies from Cornell University. She has held postdoctoral fellowships at Northwestern University, UCLA, and University of Cambridge.

Timothy M. Persons

Timothy M. Persons, PhD is a Partner of PricewaterhouseCoopers LLP leading its work in the development of innovative assurance solutions for the firm's clients in artificial intelligence/machine learning, data, algorithms, and other digital transformations to help them build and maintain trust with their customers and stakeholders. He was formerly the Chief Scientist and Managing Director of the Science, Technology Assessment, and Analytics team of the United States Government Accountability Office (GAO). In addition to founding GAO's Innovation Lab and leading advanced data analytic activities at GAO, he directed GAO's science, technology, and engineering portfolio, including technology assessment, technical assistance, and engineering sciences in support of the Congress and GAO. Prior to joining GAO, Dr. Persons served as the Technical Director for the Intelligence Advanced Research Projects Activity (IARPA) as well as the technical lead for Quantum Information Sciences and Biometrics research groups for the Information Assurance Directorate at the National Security Agency.

Arti K. Rai

Arti Rai, JD, Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy at Duke Law, is an internationally recognized expert in intellectual property law, innovation policy, administrative law, and health law. Rai's extensive research on these subjects has been funded (inter alia) by NIH, NSF, Arnold Ventures, the Kauffman Foundation, the Greenwall Foundation, and the Woodrow Wilson Center. From March to December 2021, Rai served as Senior Advisor on innovation law and policy issues to the Department of Commerce’s Office of General Counsel. She also regularly advises other federal and state agencies as well as Congress on these issues. Rai has served as a member of the National Advisory Council for Human Genome Research, as a public member of the Administrative Conference of the United States, and on numerous National Academies committees. Rai graduated from Harvard College and Harvard Law School.

Kaushik Sunder Rajan

Kaushik Sunder Rajan, PhD is Professor of Anthropology, co-Director of the Chicago Center for Contemporary Theory, and Faculty Board Member of the Pozen Center for Human Rights at the University of Chicago. He works on the political economy of the life sciences and biomedicine. He is the author of Biocapital: The Constitution of Post-Genomic Life (Duke, 2006) and Pharmocracy: Value, Politics and Knowledge in Global Biomedicine (Duke, 2017), and the editor of Lively Capital: Biotechnologies, Ethics and Governance in Global Markets (Duke, 2012). He has just completed a book on the politics of ethnography, titled Multi-situated: Ethnography as Diasporic Praxis, forthcoming with University of Chicago Press. He is currently embarked on a research project that studies the intersections of health and law in South Africa.

Krystal Tsosie

Krystal Tsosie (Diné/Navajo Nation), MPH, MA, PhD candidate is an Indigenous geneticist-bioethicist at Vanderbilt University and incoming faculty at Arizona State University. She co-founded the first US Indigenous-led biobank, a 501c3 nonprofit research institution called the Native BioData Consortium. She also serves as the 2022-2023 Global Chair of ENRICH: Equity for Indigenous Research and Innovation, which focuses on enhancing Indigenous rights to develop, control, and govern Indigenous data and supports participation in STEM and in digitally-enabled futures. Much of Tsosie’s current research centers on ethical engagement with Indigenous communities in precision health. She also incorporates biostatistics, genetic epidemiology, public health, and computational approaches to cancer health disparities, particularly in women’s health. At the laboratory bench, she developed and patented a combined targeted ultrasound imaging and chemotherapeutic drug delivery device for treating early metastases in cancer.

Katherine Bowman

Katherine Bowman, PhD is a Senior Program Officer in the Board on Health Sciences Policy and director of the consensus study on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine. Her past activities have focused on the implications of developments in science and technology, including as director of Traumatic Brain Injury: A Roadmap for Accelerating Progress (2022), co-director of the report Heritable Human Genome Editing (2020) with colleagues at the Royal Society, and director of the 2017 report Human Genome Editing: Science, Ethics, and Governance. Other recent studies in which she was involved include Biodefense in the Age of Synthetic Biology (2018) and Microbiomes of the Built Environment: A Research Agenda for Indoor Microbiology, Human Health, and Buildings (2017). She also takes part in international activities that explore advances in science and their potential impacts for biological and chemical security. She received her Ph.D. in Biomedical Engineering from Johns Hopkins University.

Meeting

Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine: Meeting #2

June 9 - 10, 2022

Past

Agenda

Download the Agenda

About

This will be a meeting of the committee developing a cross-sectoral governance framework for emerging science, technology, and innovation in health and medicine. As part of its meeting, the committee will be holding a virtual public information-gathering session with representatives from organizations providing support for the study and other invited speakers. The session will be held on June 9 from approx. 1:15-4:45pm ET via livestream. Future public, information-gathering sessions will be held in 2022 and the committee's report is expected to be released in 2023.

The open session agenda can be found below.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Keith Wailoo
Keith Yamamoto,
David Asch
Olveen Carrasquillo
Amitabh Chandra
Alta Charo
Hana El-Samad
Anthony Hatch
Lisa Iezzoni
Alex John London
Debra Mathews
Shobita Parthasarathy
Arti Rai
Kaushik S. Rajan
Krystal Tsosie

The following topics were discussed in the closed sessions:

The committee received an orientation to the National Academies study process and reviewed the study timeline. The committee members shared perspectives on elements of the task and developed an initial work plan for further information gathering and analysis.

The following materials (written documents) were made available to the committee in the closed sessions:

statement of task, study timeline, and preliminary working group/report information.

Date of posting of Closed Session Summary:

June 17, 2022

Contact

Michael Berrios

MBerrios@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine

Featured publication

Description

Collaborators

Committee

Sponsors

Staff

Parent projects

Board on Health Sciences Policy

Major units and sub-units

Contact

Contact us

Provide feedback

Request materials

More like this

Modernizing Mathematics Education for Grades 9-14

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Review of Methods in the Report on Carcinogens Handbook

National Cooperative Highway Research Program

Transit Cooperative Research Program

Modernizing Mathematics Education for Grades 9-14

State of Human H5N1 Therapeutics: A Rapid Expert Consultation

Biomedical and Health Sciences Program Area

Neurodegenerative Outcomes and Selected Military Exposures

Additional materials

Publication information

Suggested citation

About

Additional Information

Contact

Michael Berrios

Disclaimer

My Academies

Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine

Dropdown items

Featured publication

Toward Equitable Innovation in Health and Medicine: A Framework

Description

Collaborators

Committee

Sponsors

Staff

Parent projects

Board on Health Sciences Policy

Major units and sub-units

Contact

Contact us

Provide feedback

Request materials

More like this

Modernizing Mathematics Education for Grades 9-14

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Review of Methods in the Report on Carcinogens Handbook

National Cooperative Highway Research Program

Transit Cooperative Research Program

Modernizing Mathematics Education for Grades 9-14

State of Human H5N1 Therapeutics: A Rapid Expert Consultation

Biomedical and Health Sciences Program Area

Neurodegenerative Outcomes and Selected Military Exposures